La Trobe
1164314_Cao,Z_2021.pdf (733.6 kB)

Biomarkers for cancer cachexia: A mini review

Download (733.6 kB)
journal contribution
posted on 2021-06-01, 01:53 authored by Zhipeng Cao, Kening ZhaoKening Zhao, Irvin JoseIrvin Jose, Nick HoogenraadNick Hoogenraad, Laura Murray-RustLaura Murray-Rust
Cancer cachexia is a common condition in many cancer patients, particularly those with advanced disease. Cancer cachexia patients are generally less tolerant to chemotherapies and radiotherapies, largely limiting their treatment options. While the search for treatments of this condition are ongoing, standards for the efficacy of treatments have yet to be developed. Current diagnostic criteria for cancer cachexia are primarily based on loss of body mass and muscle function. However, these criteria are rather limiting, and in time, when weight loss is noticeable, it may be too late for treatment. Consequently, biomarkers for cancer cachexia would be valuable adjuncts to current diagnostic criteria, and for assessing potential treatments. Using high throughput methods such as “omics approaches”, a plethora of potential biomarkers have been identified. This article reviews and summarizes current studies of biomarkers for cancer cachexia.


This research was funded by grants from the National Health and Medical Research Council, Victorian Cancer Agency, State Government of Victoria (Department of Health and Human Services) and La Trobe University.


Publication Date



International Journal of Molecular Sciences





Article Number

ARTN 4501







Rights Statement

The Author reserves all moral rights over the deposited text and must be credited if any re-use occurs. Documents deposited in OPAL are the Open Access versions of outputs published elsewhere. Changes resulting from the publishing process may therefore not be reflected in this document. The final published version may be obtained via the publisher’s DOI. Please note that additional copyright and access restrictions may apply to the published version.